Omeros
About OmerosPipelineInvestorsNews


Investor Relations Home

Corporate Profile

Here you will find financial reports and shareholder information about Omeros Corporation, including recent news, current and historical share price, and electronic copies of our SEC filings.

 
Stock Quote
OMER (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$15.16
Change (%) Stock is Down 0.21 (1.37%)
Volume37,728
Data as of 10/17/18 9:41 a.m. ET
Minimum 20 minute delay
Refresh quote
Recent Press ReleasesMore >>
DateTitle  
10/01/18Omeros Corporation Announces Reinstatement of Pass-Through Status for OMIDRIA®
-- CMS’ Separate Payment for Cataract Surgery Drug Resumes Today -- SEATTLE--(BUSINESS WIRE)--Oct. 1, 2018-- Omeros Corporation (NASDAQ: OMER) announced that reinstatement of separate payment by the Centers for Medicare and Medicaid Services (CMS) under the pass-through program for the company’s cataract surgery drug OMIDRIA® (phenylephrine and ketorolac intraocular solution) 1% / 0.3% is effective as of today, October 1, 2018. OMIDRIA, and a ... 
 Printer Friendly Version
10/01/18Omeros Corporation Announces Additional Positive Data for OMS721 in IgA Nephropathy
-- Magnitude of Proteinuria Reduction Consistent With Previous Cohort -- SEATTLE--(BUSINESS WIRE)--Oct. 1, 2018-- Omeros Corporation (NASDAQ: OMER) today announced positive data from the company’s ongoing Phase 2 clinical trial of OMS721 for the treatment of renal diseases. The data are from study patients with immunoglobulin A (IgA) nephropathy, a progressively worsening kidney disease and the most common glomerulonephritis worldwide, respons... 
 Printer Friendly Version
09/27/18Omeros to Present at the 2018 Cantor Global Healthcare Conference
SEATTLE--(BUSINESS WIRE)--Sep. 27, 2018-- Omeros Corporation (NASDAQ: OMER), today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the 2018 Cantor Global Healthcare Conference in New York next week. The presentation is scheduled for Tuesday, October 2, 2018 at 1:05 p.m. EDT. The presentation will be webcast. The live and archived webcasts can be accessed on the “Events” page of the company’s websit... 
 Printer Friendly Version
09/07/18Omeros to Present at the Morgan Stanley Global Healthcare Conference
SEATTLE--(BUSINESS WIRE)--Sep. 7, 2018-- Omeros Corporation (NASDAQ: OMER), today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the 16th Annual Morgan Stanley Global Healthcare Conference in New York next week. The presentation, which will be a fireside chat format, is scheduled for Thursday, September 13, 2018 at 5:15 p.m. EDT. The presentation will be webcast. The live and archived webcasts can... 
 Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Featured Report
Download Documentation Corporate Presentation
Download Documentation 2017 Annual Report
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Omeros Corporation posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.